Page last updated: 2024-08-22

molybdenum and Hematologic Malignancies

molybdenum has been researched along with Hematologic Malignancies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Batinic-Haberle, I; Briehl, MM; Glinsmann-Gibson, B; Lee, K; Mazar, AP; Reboucas, JS; Rimsza, LM; Tome, ME1

Other Studies

1 other study(ies) available for molybdenum and Hematologic Malignancies

ArticleYear
The copper chelator ATN-224 induces peroxynitrite-dependent cell death in hematological malignancies.
    Free radical biology & medicine, 2013, Volume: 60

    Topics: Animals; B-Lymphocytes; Cell Death; Cell Survival; Chelating Agents; Copper; Hematologic Neoplasms; Humans; Mice; Molybdenum; Oxidative Stress; Peroxynitrous Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Primary Cell Culture; Proto-Oncogene Proteins c-bcl-2; Stress, Physiological; Superoxide Dismutase; Superoxide Dismutase-1; U937 Cells

2013